Myrrh

What it is

Myrrh is an aromatic resin that seeps from incisions in the bark of Commiphora trees (primarily C.myrrha and C.molmol), growing in arid regions of East Africa and the Arabian Peninsula. The resin hardens in air into characteristic tear-shaped brownish-amber pieces.

Myrrh is one of the few ingredients mentioned simultaneously in the Bible, Quran, ancient Egyptian papyri and the works of Hippocrates. Egyptians used it for embalming and treating oral wounds; Greek physicians applied it to periodontal disease. It was present in the European pharmacopoeia into the 20th century.

Active components include furano-sesquiterpenes (curcumenes, liddesol), diterpenoids (commiphoric acid) and polysaccharide resins. The curcumenes determine the antiseptic and mild anaesthetic profile.

How it works

Cellular membrane disruption. Furano-sesquiterpenes from myrrh oil integrate into the phospholipid bilayer of bacterial membranes, increasing their permeability and causing ion leakage. This mechanism explains the broad spectrum against gram-positive (S.aureus, S.mutans, Enterococcus) and gram-negative (P.gingivalis, E.coli) bacteria.

Antifungal effect. Curcumenes inhibit ergosterol biosynthesis — a key component of Candida cell walls. This makes myrrh effective against candidal stomatitis, where most antibacterial herbs are ineffective.

Local anaesthesia. Dolara et al. (2000) showed that certain sesquiterpenes from myrrh oil block sodium channels analogously to procaine — hence the mild analgesic effect when applied to inflamed mucosa.

Astringent effect. Myrrh's polysaccharide resins bind to mucosal proteins, forming a protective barrier over ulcers and erosions. This effect is particularly valuable in stomatitis: the barrier reduces contact between nerve endings and irritants.

Efficacy

Al-Mobeeriek (2011) in a clinical trial showed that application of myrrh tincture to aphthous ulcers three times daily reduced epithelialisation time from 10–12 to 6–7 days and significantly reduced the pain index from the first day of use.

Omer et al. (2011) confirmed activity of Commiphora extract against major periodontal pathogens — P.gingivalis, T.forsythia — with MIC 0.1–0.5 mg/mL, corresponding to concentrations achievable in mouthwashes. Tipton et al. (2003) demonstrated anti-inflammatory effects in gingival fibroblast cells without cytotoxicity at therapeutic concentrations.

Safety

Myrrh has safe ingredient status (CIR, SCCS). When applied topically in the oral cavity, systemic absorption is negligible. The specific bitter-resinous taste is a technological challenge requiring balancing.

Not recommended during pregnancy at high concentrations (traditionally used to stimulate uterine activity in some ethnomedicinal systems — at oral concentrations up to 1% the risk is practically zero, but the recommendation remains).

Role in the QDRO formula

Myrrh provides antiseptic "depth" in v.pro mouthwashes. Unlike eucalyptol and thymol (synthetic terpenes in the Listerine pattern), myrrh adds an antifungal and astringent profile. It combines excellently with neem (antibacterial base) and propolis (film-forming). Concentrations up to 1% do not require additional flavour masking with a well-designed aromatic composition.